Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study

Hdl Handle:
http://hdl.handle.net/10144/303529
Title:
Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study
Authors:
Maskew, Mhairi; Fox, Matthew P; van Cutsem, Gilles; Chu, Kathryn; Macphail, Patrick; Boulle, Andrew; Egger, Matthias; for IeDEA Southern Africa
Journal:
PLoS One
Abstract:
Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has focused attention on AIDS-related cancers including Kaposi sarcoma (KS). However, the effect of KS on response to ART is not well-described in Southern Africa. We assessed the effect of KS on survival and immunologic and virologic treatment responses at 6- and 12-months after initiation of ART.
Affiliation:
Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. mmaskew@heroza.org
Issue Date:
Jun-2013
URI:
http://hdl.handle.net/10144/303529
DOI:
10.1371/journal.pone.0064392
PubMed ID:
23755122
Language:
en
ISSN:
1932-6203
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorMaskew, Mhairien_GB
dc.contributor.authorFox, Matthew Pen_GB
dc.contributor.authorvan Cutsem, Gillesen_GB
dc.contributor.authorChu, Kathrynen_GB
dc.contributor.authorMacphail, Patricken_GB
dc.contributor.authorBoulle, Andrewen_GB
dc.contributor.authorEgger, Matthiasen_GB
dc.contributor.authorfor IeDEA Southern Africaen_GB
dc.date.accessioned2013-10-16T21:18:37Z-
dc.date.available2013-10-16T21:18:37Z-
dc.date.issued2013-06-
dc.identifier.citationTreatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study. 2013, 8 (6):e64392 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid23755122-
dc.identifier.doi10.1371/journal.pone.0064392-
dc.identifier.urihttp://hdl.handle.net/10144/303529-
dc.description.abstractImproved survival among HIV-infected individuals on antiretroviral therapy (ART) has focused attention on AIDS-related cancers including Kaposi sarcoma (KS). However, the effect of KS on response to ART is not well-described in Southern Africa. We assessed the effect of KS on survival and immunologic and virologic treatment responses at 6- and 12-months after initiation of ART.en_GB
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.subjectHIV/AIDSen_GB
dc.titleTreatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Studyen
dc.contributor.departmentHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. mmaskew@heroza.orgen_GB
dc.identifier.journalPLoS Oneen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.